Thieme Chemistry News

Latest News and Updates from the Thieme Chemistry Editorial Offices

Keep up to date on the latest topics in organic chemistry, synthesis, drug research, and pharmaceutics. Here you can find news from the editorial boards and the editorial offices. We also share the most important information about our Thieme Chemistry portfolio, journals, and databases.

News and Updates from Thieme Chemistry

Price made of glass with star on blue background

SCNOW Outstanding Paper Award Winner

Stuttgart, June 2026 – We are pleased to announce the winner of the inaugural Sustainability & Circularity NOW SCNOW Outstanding Paper Award, recognizing excellence among papers published in the journal over the past year.

Price made of glass with star on blue background

SYNTHESIS Best Paper Award Winners 2025

Stuttgart, June 2026 – Samer Gnaim, Julien C. Vantourout, and Pierre‑Georges Echeverria for SYNTHESIS, together with their co‑authors, are the recipients of the 2025 SYNTHESIS Best Paper Award.

Price made of glass with star on blue background

SYNLETT Best Paper Award Winners 2025

Stuttgart, June 2026 – Go Hirai and Kazuteru Usui for SYNLETT, together with their co‑authors, are the recipients of the 2025 SYNLETT Best Paper Award.

SynOpen Award Winners 2025

SynOpen Most Innovative Paper Award Winners 2025

Stuttgart, June 2026 – Yi Jin, Limei Qian and Ming Yang together with their co-authors, are the recipients of the 2024 Most Innovative Paper Award for SynOpen.

Portrait of Professor Song Lin

IUPAC Award Winner 2026

Stuttgart, April 2026 – Thieme and the editors of SYNTHESIS, SYNLETT, SYNFACTS, and Science of Synthesis together with the International Union of Pure and Applied Chemistry (IUPAC) award Song Lin (Cornell University, USA) with the 2026 Thieme–IUPAC Prize in recognition of his pioneering work in electrochemical methods that are advancing organic synthesis and enabling more sustainable chemical processes.

Chemistry Journal Therapeutics NOW

New OA Journal Therapeutics NOW

Stuttgart, January 2026 – Thieme is expanding its open access portfolio to advance evidence-based therapeutic development. The new journal Therapeutics NOW will publish high-quality research in gene therapy, immunotherapy, drug discovery, targeted delivery systems, and personalized medicine. Authors can benefit from fast, professional peer review and efficient open access publication with global visibility.

Logo Fachinformationsdienst Chemie (FID)

Funded Access to SOS for German Institutions

Stuttgart, May 2026 – Thieme has signed a three‑year national agreement with the newly established FID Chemie – Fachinformationsdienst Chemie (Chemistry Information Service) to provide synthetic organic chemists nationwide with access to the Science of Synthesis (SOS) Platform, Thieme’s reference database for synthetic chemistry.